Heartflow, Inc. insider trading
Every open-market purchase and sale by Heartflow, Inc.'s officers, directors and largest shareholders since November 4, 2021, and what the share price did next.
Insider purchases, 5 years $1.1M 1 trade by 1 insider
3 months later: median −14.9% (−14.0% vs S&P 500) Insider sales, 5 years $141M 37 trades by 6 insiders
3 months later: median +25.3% (+11.2% vs S&P 500)
| Date | Insider | Trade | Shares | Price | Value | 1M after | 3M after | 6M after |
|---|
Does following Heartflow, Inc.’s insiders pay?
From December 17, 2025 to April 30, 2026, 3 insiders reported 1 open-market purchase and 2 sales not made under a pre-set plan in Heartflow, Inc. Buying each purchase the day after it was reported, an equal amount each, held 12 months or until that insider reported a sale, would have turned $10,000 on December 18, 2025 into $19,019 by November 2, 2026, +110.3% a year. It held shares 100% of the time; the S&P 500 on those same days, with Treasury bills otherwise, made $11,303 (+15.2% a year), and held throughout $11,303 (+15.2%).
| Insider | Role | Purchases | 12 months after their purchases | Beat the S&P 500 | Sales | 12 months after their sales | Latest report |
|---|---|---|---|---|---|---|---|
| Bain Capital Life Sciences III General Partner, LLC | 10% owner | 0 | — | — | 1 | — | April 30, 2026 |
| Bain Capital Life Sciences Investors, LLC | 10% owner | 0 | — | — | 1 | — | February 6, 2026 |
| Lightcap Jeffrey C | Director | 1 | — | — | 0 | — | December 17, 2025 |